JPS617290A - Triterpene-type saponin compound - Google Patents
Triterpene-type saponin compoundInfo
- Publication number
- JPS617290A JPS617290A JP12640984A JP12640984A JPS617290A JP S617290 A JPS617290 A JP S617290A JP 12640984 A JP12640984 A JP 12640984A JP 12640984 A JP12640984 A JP 12640984A JP S617290 A JPS617290 A JP S617290A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- glucuronic acid
- triterpene
- molecule
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
本発明はトリテルペン系サポニン化合物に関するもので
ある。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to triterpene saponin compounds.
本発明者等は、種々の植物に含まれる生理活性物質を探
索している過程において、ツバキの葉に含まれるある種
の化合物が各種の植物病原菌等の有害な微生物に対して
優れた抗菌活性を有することを確認L、この知見に基い
て本発明を完成した。In the process of searching for physiologically active substances contained in various plants, the present inventors discovered that certain compounds contained in camellia leaves have excellent antibacterial activity against harmful microorganisms such as various plant pathogens. The present invention was completed based on this knowledge.
すなわち、本発明の要旨は、
〔式中R1は水素原子又はアセチル基を示し、R2は1
分子のグルクロン酸、1分子のグルコース及び2分子の
ガラクトースがらなり、かつグルクロン酸がアグリコン
に直接結合してなる糖鎖な示す。〕
で表わされるトリテルペン系サポニン化合物に存する。That is, the gist of the present invention is [wherein R1 represents a hydrogen atom or an acetyl group, and R2 represents 1
A sugar chain consisting of a molecule of glucuronic acid, one molecule of glucose, and two molecules of galactose, and in which glucuronic acid is directly bonded to an aglycone. ] It consists of triterpene saponin compounds represented by
本発明を1iP4111に説明すると、前示〔0式で示
される本発明の化合物は、文献未載の新規化合物で、分
子式+’L 0asHaa02s及びcgaHa40H
であり、その比旋光度、 IR吸収スペクトル、マスス
ペクトル。To explain the present invention to 1iP4111, the compound of the present invention represented by the above formula
and its specific rotation, IR absorption spectrum, and mass spectrum.
”H−NMR及び”C!−NMRの測定結果は後記実施
例に示した通りである。本発明の化合物を、例えば稀硫
酸及びジオキサンの混合液中で加水分解すれば、アグリ
コン(非糖部分)に由来するカメリアゲニン(Oame
lliagenin ) F [日本薬学会館88年会
講演要旨集、256頁6G4−2(1968年)参照〕
が得られる。また、上記加水分解生成物からカメリアゲ
ニンFを除去した糖部分は、その薄層クロマトグラフィ
ー及び該糖部分のトリメチルシリル化物のガスクロマト
グラフィーの測定結果から、1分子のグルクロン酸、1
分子のグルコース及び2分子のガラクトースからなるこ
とが示された。“H-NMR and”C! -NMR measurement results are as shown in Examples below. If the compound of the present invention is hydrolyzed, for example, in a mixture of dilute sulfuric acid and dioxane, cameliagenin (Oame
lliagenin) F [Refer to Proceedings of the 1988 Annual Meeting of the Pharmaceutical Society of Japan, p. 256 6G4-2 (1968)]
is obtained. Furthermore, from the results of thin layer chromatography and gas chromatography of the trimethylsilylated sugar moiety, the sugar moiety from which cameliagenin F was removed from the hydrolyzed product was found to contain one molecule of glucuronic acid, one molecule of glucuronic acid, and one molecule of glucuronic acid.
It was shown to consist of one molecule of glucose and two molecules of galactose.
さらに、本発明の化合物のうち、前足CI)式における
R8がアセチル基である化合物をピリジン及び無水酢酸
中で還流上加熱すると、〔13式におけるR、及びR2
が共にアセチル基であるジアセテート体が生成する。こ
のことよりグルクロン酸がアグリコンに直接結合してい
ることが明らかとなり、本発明の化合物の構造が確認さ
れた。Furthermore, among the compounds of the present invention, when a compound in which R8 in the forepaw CI) formula is an acetyl group is heated under reflux in pyridine and acetic anhydride, [R in formula 13 and R2
A diacetate compound in which both are acetyl groups is produced. This revealed that glucuronic acid was directly bonded to the aglycone, and the structure of the compound of the present invention was confirmed.
本発明の化合物は、後記実施例に詳述するように、例え
ばツバキの葉を細断し、水又は適当な有機溶媒を用いて
抽出処理し、得られた抽出液を適当な吸着剤及び溶離剤
を用いたカラムクロマトグラフィーによって分画し、活
性画分を採取し、さらに精製処理を繰返すことによって
単離することができる。The compounds of the present invention can be obtained by, for example, shredding camellia leaves and extracting them using water or an appropriate organic solvent, and using the resulting extract with an appropriate adsorbent and eluent, as detailed in the Examples below. It can be isolated by fractionating it by column chromatography using a reagent, collecting an active fraction, and repeating the purification process.
本発明の化合物は、後記試験例に示すように、チャ炭そ
病、チャ輪斑病、イネいもち病、イネごま葉枯病菌等各
種の植物病原糸状菌に対して優れた抗菌作用を示すこと
から、これら有害微生物の防除剤としての用途が期待さ
れる。以下本発明を実施例及び試験例によって更に詳細
に説明する。As shown in the test examples below, the compound of the present invention exhibits excellent antibacterial activity against various plant pathogenic fungi such as tea anthracnose, tea leaf spot, rice blast, and rice sesame leaf blight. Therefore, it is expected to be used as a control agent for these harmful microorganisms. The present invention will be explained in more detail below with reference to Examples and Test Examples.
実施例1
ヤブツバキ(紅唐子)の葉3.2kgを10倍量の水と
ともにミキサーにかけてパルプ状に磨砕(2,120℃
、5分間加熱後p過し、25.6 /の抽出液を得た。Example 1 3.2 kg of leaves of Camellia japonica were ground into pulp (2,120°C) in a mixer with 10 times the amount of water.
After heating for 5 minutes, filtration was performed to obtain an extract having a concentration of 25.6%.
この抽出液各3.24宛、乾燥型で60gの、Ol−型
としたI)]]1iAE−セルローを充填した5、0
cIILX 45.0 cmのカラムにかけ、溶離液と
してI M NaC1水溶液を4e流して活性成分を
溶出させた。このNa (J lを含む活性成分水溶液
から活性成分を等1のn−ブタノ、−ルに:Itり取り
、減圧上濃縮乾固して、n−ブタノール・エタノール・
水(60:20:20)に再溶解し、合計400℃ノの
溶液を得た。この溶液20 ml宛、150gのシリカ
ゲル(n−ブタノールに懸濁)を充填した2、Ocrr
t X 90.0儂のカラムにかけ、n−ブタノール2
401、ついで上記n−ブタノール・エタノール・水混
合液500 mlを4 me 7分の割合で流し、37
個の両分に分け、活性成分を含む25〜350両分を採
取し、減圧上濃縮乾固した。とねを上記n−ブタノール
・エタノール・水混合液1.Qmtに溶解し、各100
μl宛、1.0cnL×25crfLの分取用オクタデ
シルシラン(ODS −Olg )カラムを用いた高速
液体クロマトグラフィーにかけ、アセトニトリル・水・
酢酸(37,0: 62.9 : 0.1 )を溶離液
として各6.Oml宛分画し、本発明の化合物人(前足
〔13式におけるR1がアセチル基である化合物)及び
化合物B(前足〔13式におけるR1が水素原子である
化合物)を夫々単離した。3.24 each of this extract, 60 g in dry form, in Ol-form I)]]1iAE-cellulose-filled 5,0
The active ingredient was eluted by applying it to a cIILX 45.0 cm column and flowing 4 e of I M NaCl aqueous solution as an eluent. From this active ingredient aqueous solution containing Na (Jl), the active ingredient was taken as 1 n-butanol, -l, and concentrated to dryness under reduced pressure to form n-butanol, ethanol, and
It was redissolved in water (60:20:20) to obtain a solution at a total temperature of 400°C. 2, Ocrr filled with 150 g of silica gel (suspended in n-butanol) to 20 ml of this solution.
of n-butanol 2
401, then 500 ml of the above n-butanol/ethanol/water mixture was poured at a rate of 4 me 7 minutes, and 37
The mixture was divided into two portions, and 25 to 350 portions containing the active ingredient were collected and concentrated to dryness under reduced pressure. Add the above n-butanol/ethanol/water mixture 1. Dissolved in Qmt, each 100
μl was subjected to high performance liquid chromatography using a preparative octadecylsilane (ODS-Olg) column of 1.0 cnL x 25 crfL.
6 each using acetic acid (37.0:62.9:0.1) as the eluent. The compound of the present invention (forepaw [compound in which R1 in formula 13 is an acetyl group]) and compound B (forepaw [compound in which R1 in formula 13 is a hydrogen atom]) of the present invention were isolated.
これらの化合物は種々の薄層クロマトグラフィー〔シリ
カゲル(クロロホルム:メタノール:水=65 : 3
5 : 10.下層;n−ブタノール:酸1駿:水−4
: 1 : 1.5 ) )及び高速液体クロマトグラ
フィー(ODS −01g 、 5μ、メタノール:水
=65:35)測定の結果から純品であることが1明し
た。These compounds were analyzed by various thin layer chromatography [silica gel (chloroform:methanol:water=65:3
5: 10. Lower layer: n-butanol: 1 acid: 4 water
The results of measurements by high performance liquid chromatography (ODS-01g, 5μ, methanol:water = 65:35) revealed that it was a pure product.
なお、本実施例における分離、精製過程での生理活性の
測定は、後記試験例1及び2の試験法に従って行った。Note that the measurement of physiological activity during the separation and purification process in this example was carried out in accordance with the test methods described in Test Examples 1 and 2 below.
上記化合物A及び化合物Bの比旋光度、 IRスペクト
ル、マススペクトル、 ”I(−NMR及び130−
NMRの測定結果は次の通りであった。Specific rotation, IR spectrum, mass spectrum, "I(-NMR and 130-
The NMR measurement results were as follows.
化合物A:〔(χ〕名5+2°(c O−5,0R40
H) i IR(K]3r) 3600〜3200.1
710cm ; fiIMs m/’L1191 (M
+2Na−E)、1169 (M十Na )、 11
029(163+2Na )、867(M−325+2
Na)、727(M−442+−Na)、565(M−
604+Na)、 365(0,IIH,。Ol 、
7ト Na ) i’H−NMR(500RfH2
,P’Y−ds ’ D20 ” 0.4 :
0.05Id、+100℃)δ0.901 (3H,s
)、 0.918(3)L s )。Compound A: [(χ] name 5+2°(c O-5,0R40
H) i IR(K]3r) 3600-3200.1
710cm; fiIMs m/'L1191 (M
+2Na-E), 1169 (M+Na), 11
029(163+2Na), 867(M-325+2
Na), 727 (M-442+-Na), 565 (M-
604+Na), 365(0,IIH,.Ol,
7 Na) i'H-NMR (500RfH2
,P'Y-ds'D20'' 0.4:
0.05Id, +100℃) δ0.901 (3H,s
), 0.918(3)L s ).
1.00(3H,s )、1.094 (3H,s )
、1.209(3H,s )。1.00 (3H,s), 1.094 (3H,s)
, 1.209 (3H,s).
1.289 (3H,s)、1.296(3H,s )
、2.147 (3■1.s)。1.289 (3H, s), 1.296 (3H, s)
, 2.147 (3■1.s).
2.410(IH,at、、T=13,311z)、3
.026(IH,dt、J =13.31h)、3.2
84(IH,m)、3.580(IH,m)、3.69
2(IH,m)、5.603(IH,6,J=7.61
(z)、5.637(IH,d。2.410 (IH, at, , T = 13,311z), 3
.. 026 (IH, dt, J = 13.31h), 3.2
84 (IH, m), 3.580 (IH, m), 3.69
2 (IH, m), 5.603 (IH, 6, J = 7.61
(z), 5.637 (IH, d.
J=7.6Hz)、 5.678 (III、 d、
J=3.711z) i”O−NMR(22,5MII
z、 Py−aa ’ D20 =0.4 : 0.1
5wLl。J=7.6Hz), 5.678 (III, d,
J=3.711z) i”O-NMR(22,5MII
z, Py-aa' D20 =0.4: 0.1
5wLl.
+100°C)δ14.93. 16.34 、 17
.33 、 18.09 。+100°C) δ14.93. 16.34, 17
.. 33, 18.09.
20.38 、 23.42 、 25.82 、
26.47 、 27.87 。20.38, 23.42, 25.82,
26.47, 27.87.
30.33 、 30.51 、 32.09 、
33.03 、 36.66 。30.33, 30.51, 32.09,
33.03, 36.66.
38.53 、 39.06 、 40.05 、
46.73 、 47.73 。38.53, 39.06, 40.05,
46.73, 47.73.
47.84 、 52.41 、 55.81 、
61.55 、 62.01 。47.84, 52.41, 55.81,
61.55, 62.01.
63.83 、 69.16 、 69.39 、
69.68 、 70.68 。63.83, 69.16, 69.39,
69.68, 70.68.
70.01 、 72.85 、 73.84 、
74.66 、 75.83 。70.01, 72.85, 73.84,
74.66, 75.83.
76.36 、 76.60 、 77.00 、 7
B、70 、 79.41 。76.36, 76.60, 77.00, 7
B, 70, 79.41.
80.48 、 82.39 、 89.77 、
90.18 、 100.37 。80.48, 82.39, 89.77,
90.18, 100.37.
102.36. 104.35 、 124.26
、 141.42 、 171.86゜175.03.
215.61 。102.36. 104.35, 124.26
, 141.42, 171.86°175.03.
215.61.
化合物B : 〔aa1.−6°(co、5. On’
60IJ) i IR(K]3r)3600〜32o0
,171ocTL−1;S IMS m/z 114.
9 (M+2Na−II)、 1127 (M+Na
)、 987(Rト163+2Na、)、825(M−
325+2Na)、685(M −4421−Na)、
523(M 604+Na)、365(0+JT9*
Ott十Na);
’H−NMR(50ON[Iz、 py−d5+ +1
00’C)δ0.908 (311゜s)、 0.94
6(3)1. s)、 0.996(3E1. s)、
1.113(3B、3)。Compound B: [aa1. -6°(co, 5. On'
60IJ) i IR(K]3r)3600~32o0
, 171ocTL-1; SIMS m/z 114.
9 (M+2Na-II), 1127 (M+Na
), 987 (Rt163+2Na, ), 825 (M-
325+2Na), 685(M-4421-Na),
523 (M 604+Na), 365 (0+JT9*
'H-NMR (50ON[Iz, py-d5+ +1
00'C) δ0.908 (311°s), 0.94
6(3)1. s), 0.996 (3E1.s),
1.113 (3B, 3).
1.219(3I−1’、 s )、 1.27(1(
3H,s )、 1.304(3H,s) 。1.219(3I-1', s), 1.27(1(
3H,s), 1.304(3H,s).
2.415 CITJ’、 dt、 、■=13
. 3Hz)、 3.00 (IH,brd 、
J =13Hz)、 3.30(In、 m)、
3.92(IH,d、 J=15.5Hz) i’ 8
Q−NMR,(22,5Fllllz、 Py−65,
+1.00’C)δ15.69 。2.415 CITJ', dt, ,■=13
.. 3Hz), 3.00 (IH,brd,
J = 13Hz), 3.30 (In, m),
3.92 (IH, d, J=15.5Hz) i' 8
Q-NMR, (22,5Fllllz, Py-65,
+1.00'C) δ15.69.
δ7.】6. J、s、o4. 18.9]、 、
24.13 、 27L35 。δ7. ]6. J, s, o4. 18.9], ,
24.13, 27L35.
28.69 、 31.04 、 31.68 、 3
2.79 、 33.73 。28.69, 31.04, 31.68, 3
2.79, 33.73.
37.42. コ(9,76、40,70、48,
43、53,23。37.42. Ko (9, 76, 40, 70, 48,
43, 53, 23.
56.45 、 fi2.48 、 63.01 、
70.33 、 70.91 。56.45, fi2.48, 63.01,
70.33, 70.91.
71.15 、 71.91 、 73.73 、 7
3.96 、 74.60 。71.15, 71.91, 73.73, 7
3.96, 74.60.
75.01 、 75.42 、 76.19 、 7
6.30 、 76.71 。75.01, 75.42, 76.19, 7
6.30, 76.71.
78.00 、 79.29 、 81.9B 、
84.03 、 90.30 。78.00, 79.29, 81.9B,
84.03, 90.30.
101.66 、103.12 、105.05 、1
05.伺、 124.50 。101.66, 103.12, 105.05, 1
05. Visit, 124.50.
142.53 、 175.79 、 213.97゜
前記本発明の化合物Aを7%硫酸・ジオキサン(3:1
)中速流下で3時間加熱した後、クロロホルム層を水層
から分離し、溶媒を除去して得た残渣について機器分析
した結果、既知のカメリアゲニンrと同一物であること
が判明した。142.53, 175.79, 213.97° Compound A of the present invention was mixed with 7% sulfuric acid/dioxane (3:1
) After heating under medium-speed flow for 3 hours, the chloroform layer was separated from the aqueous layer, the solvent was removed, and the resulting residue was subjected to instrumental analysis and was found to be the same as the known cameliagenin r.
一方、上記クロロホルム層を餘去した水層に水酸化バリ
ウムを加えて中和し、蒸発乾固した糖部分をヘキサメチ
ルジシラザン・トリメチルクロロシラン・ピリジン(2
:1 :10)に溶解し、室温で30分放置することに
よりトリメチルシリルエーテル体を得た。同濃度のグル
コース及びガラクトースの標準液を同様にして夫々トリ
メチルシリル化し、両者のガスクロマトグラフィー及び
GOマススペクトル測定結果を比較することによって前
記グルクロン酸以外の糖部分の構造がグルコース1分子
、ガラクトース2分7と同定された。On the other hand, barium hydroxide was added to the aqueous layer after removing the chloroform layer to neutralize it, and the sugar portion was evaporated to dryness.
:1 :10) and allowed to stand at room temperature for 30 minutes to obtain a trimethylsilyl ether. Standard solutions of glucose and galactose at the same concentration were similarly trimethylsilylated, respectively, and the results of gas chromatography and GO mass spectrometry measurements were compared. It was identified as 7.
また、化合物AをIN硫酸・ジオキサン(1:1)中で
還流下1時間加熱した後、上記の方法で糖部分を調製し
、薄層クロマミグラフイー(アビセル、酢酸エチル・ピ
リジン・酢酸・水−5:5:1:3)で標本のグルクロ
ン酸と比較1゛ることによってグルクロン酸を同定した
。In addition, after heating Compound A under reflux in IN sulfuric acid/dioxane (1:1) for 1 hour, the sugar moiety was prepared by the above method, and thin layer chromamigraphy (Avicel, ethyl acetate, pyridine, acetic acid, The glucuronic acid was identified by comparing it with the glucuronic acid of the sample using water (5:5:1:3).
さらに、前記化合物Aを無水酢酸・ピリジン(1:l)
とともに還流下1時間加熱すると、前記糖部分かアセチ
ル基で置換された式
で示されるアグリコンのアセテート体が得られる。Furthermore, the compound A was mixed with acetic anhydride/pyridine (1:l).
When the mixture is heated under reflux for 1 hour, an acetate of the aglycone represented by the formula in which the sugar moiety is substituted with an acetyl group is obtained.
コノ事実は、IR(KBr) 1735 、 1710
am ’ iMS m/z 526 ; ’H−NM
R(90MHz、 CD(1!t8)δo、87(91
(、brs)、 0.96(3H,s)、 0.98(
3H,s)、 1.07(3、Tf、 s )、 l
−16(3H,s )、 2.03 (3i4. s
)、 2.05(3H,s)。The facts are IR (KBr) 1735, 1710
am' iMS m/z 526;'H-NM
R(90MHz, CD(1!t8)δo, 87(91
(,brs), 0.96(3H,s), 0.98(
3H,s), 1.07(3,Tf,s), l
-16 (3H,s), 2.03 (3i4.s
), 2.05 (3H, s).
4.49(iiL brt、、 J=8Hz)、 5.
42(LH,t、 J=3Hz)等の測定結果から確1
された。従って、グルクロン酸がアグリコンに直接結合
していることが確認された。[Chemical Ph
armaceutical Bulletin 。4.49 (iiL brt, J=8Hz), 5.
42 (LH, t, J=3Hz) etc., it is certain that
It was done. Therefore, it was confirmed that glucuronic acid was directly bound to the aglycone. [Chemical Ph
armaceutical Bulletin.
25巻、1408頁(1977年)参照〕実施例2
ヤブツパキ(乙女椿)の葉7.5に9を液体窒素で凍結
した後、粉砕し、次いで201のメタノールで抽出処理
した。得られた抽出液を減圧下で濃縮してメタノールを
除き600gの抽出物を得た。25, p. 1408 (1977)] Example 2 After freezing 7.5 to 9 leaves of Camellia japonica (Otome Camellia) in liquid nitrogen, they were crushed, and then extracted with 201 methanol. The obtained extract was concentrated under reduced pressure to remove methanol and obtain 600 g of extract.
得られた抽出液を減圧下で濃縮してメタノールを除き6
001の抽出物を得た。この抽出物を5等分し、400
.litのシリカゲルを充填した5、6t1mX35.
0cIILのカラム5本にかけ、溶離液として酢酸エチ
ル・エタノールC31毎にメタノールを10%づつ増加
させる)を用いて溶出させ、活性成分を含む酢酸エチル
・メタノール(60:40)の溶出画分を採取し、濃縮
した。次いで、これを上記と同一容量のシリカゲル充填
カラムにかけ、溶離液としてクロロホルム・メタノール
・水(65: 35 : 10.下層)を用いて溶出さ
せ、各11宛22個の両分に分けた。該画分から活性成
分を含む9〜120両分を採取し、減圧下に濃縮して3
.625 、litの残渣を得た。この残渣をメタノー
ルに溶解し、再沈澱させることにより2.1289の沈
澱物を得た。The obtained extract was concentrated under reduced pressure to remove methanol.
001 extract was obtained. Divide this extract into 5 equal parts, 400
.. 5,6t1m×35.lit filled with silica gel.
Apply to 5 columns of 0cIIL and elute with ethyl acetate/ethanol (increasing methanol by 10% for each C31) as eluent, and collect the eluted fraction of ethyl acetate/methanol (60:40) containing the active ingredient. and concentrated. Next, this was applied to a silica gel packed column of the same capacity as above, eluted using chloroform/methanol/water (65:35:10, lower layer) as an eluent, and divided into 22 portions of 11 each. From this fraction, 9 to 120 fractions containing the active ingredient were collected and concentrated under reduced pressure.
.. A residue of 625, lit was obtained. This residue was dissolved in methanol and reprecipitated to obtain a precipitate of 2.1289.
上記の沈澱物を更に同様にして400gのシリカゲルを
充填した3、5 cm X i 00.Ocmのカラム
にかケ、クロロホルム・メタノール・水(65:35:
10.下層)を溶離液として各100m1宛分画し、本
発明の化合物A(前足[I)式におけるR1がアセチル
基である化合物)及び化合物B(前足〔13式における
RQが水素原子である化合物)を夫夫単離l、た。The above precipitate was further prepared in a similar manner to form a 3.5 cm X i 00. Add chloroform/methanol/water (65:35:
10. The lower layer) was fractionated into 100 ml portions each as an eluent, and the compounds of the present invention A (a compound in which R1 in the front foot [I) formula is an acetyl group] and compound B (a compound in which RQ in the front foot [formula 13] is a hydrogen atom) were obtained. The husband was isolated.
なお、本実施例における分離、精製過程での生理活性の
測定は、後記試験例3及び4の試験法に従って行った。Note that the measurement of physiological activity during the separation and purification process in this example was carried out in accordance with the test methods described in Test Examples 3 and 4 below.
ここに得られた化合物A及び化合物Bの比旋光i、IR
スペクトル、マススペクトル、 ”H−NMR及び”
0−NMRの測定結果は曲水実施例1の通りであった。Specific rotation i, IR of compound A and compound B obtained here
Spectrum, mass spectrum, "H-NMR and"
The 0-NMR measurement results were as in Example 1.
試験例1 チャ炭そ病菌胞子発芽阻害試験ホールグラス
上に所定濃度の前記実施例1における化合物Aの水溶液
50μlと、茶菓培地(チャの成葉をそのまま高圧殺菌
したもの)で培養したチャ炭そ病菌(Gloeospo
rium theaesinensis )胞子のポテ
トシュークロース液体培地懸濁液50μlを分注し、混
合したのち24℃の温室で24時間培養後、胞子の発芽
数、発芽状態を顕微鏡で計測した。Test Example 1 Tea anthracnose fungus spore germination inhibition test 50 μl of the aqueous solution of Compound A in Example 1 at a predetermined concentration on a whole glass, and tea anthracnose cultured in Chaka culture medium (adult leaves of tea leaves directly high-pressure sterilized). Disease germs (Gloeospo)
50 μl of a suspension of S. rium theaesinensis) spores in a liquid potato sucrose medium was dispensed, mixed, and cultured in a greenhouse at 24° C. for 24 hours. The number of germinated spores and the state of germination were measured using a microscope.
結果は、表−1に示す通りであった。The results were as shown in Table-1.
口、胞子異常度は、化合物Aの作用で胞子が異常に膨化
して菌糸が正常に生育しない程度を1〜5(5が最強)
に分けて示す。The degree of spore abnormality is 1 to 5 (5 is the strongest), which is the degree to which spores expand abnormally due to the action of compound A and hyphae do not grow normally.
Shown separately.
試験例2 チャ輪斑病菌胞子発芽阻害試験ホールグラス
上に所定濃度の前記実施例1における化合物Aの水溶液
501tllと、茶菓培地(チャの成葉をそのまま高圧
殺菌したもの)で培養したチャ輪斑病菌(Pe5tal
otia longiseta )胞子のポテトシュー
クロース液体培地懸濁液50μノを分注し、混合したの
ち24℃の温室で24時間培養後、胞子の発芽数1発芽
状態を顕微鏡で計測した。Test Example 2 Tea leaf spot fungus spore germination inhibition test Char leaf spot cultured on a whole glass with 501 tll of aqueous solution of Compound A in Example 1 at a predetermined concentration and chaka culture medium (adult leaves of tea leaves sterilized under high pressure) Disease germs (Pe5tal
otia longiseta) spores in a liquid medium of potato sucrose was dispensed, mixed, and cultured for 24 hours in a greenhouse at 24°C. The number of germinated spores (1) was measured using a microscope.
結果は、表−2に示す通りであった。The results were as shown in Table-2.
(注) イ、胞子発芽数と胞子発芽率は、正常胞子発芽
数と率を示す。(Note) A. The number of spore germination and spore germination rate indicate the number and rate of normal spore germination.
口、発芽管異常度は、化合物Aの作用で発芽管が異常に
V化して正常に生育しな(・程度を1〜5(5が最強)
に分けて示す。The degree of germ tube abnormality is determined by the action of Compound A, which causes germ tubes to become abnormally V-shaped and fail to grow normally.
Shown separately.
試験例3 イネいもち病菌胞子発芽阻害試験ホールグラ
ス上に所定濃度の前記実施例2における化合物Aの水溶
液50μlと、オートミール培地で培養したイネいもち
病菌(Pyricularia oryzae )の1
%グルコース含有胞子懸濁液50μlを分注して混合し
たのち27℃の溝室で12時間培養後、胞子の発芽数を
顕微鏡で計測した。Test Example 3 Rice blast fungus spore germination inhibition test 50 μl of the aqueous solution of Compound A in Example 2 at a predetermined concentration was placed on a whole glass, and 1 of rice blast fungus (Pyricularia oryzae) cultured in an oatmeal medium was placed on a whole glass.
After dispensing and mixing 50 μl of a spore suspension containing % glucose, the mixture was cultured in a groove chamber at 27° C. for 12 hours, and the number of germinated spores was counted using a microscope.
結果は、表−3に示す通りであった。The results were as shown in Table-3.
表−3
(注) イ、胞子発芽数と胞子発芽率は、正常胞子発芽
数と率を示す。Table 3 (Note) A. Number of spore germination and spore germination rate indicate the number and rate of normal spore germination.
試験例4 イネごま葉枯病菌胞子発芽阻害試験ポールグ
ラス上に所定濃度の前記実施例2における化合物Aの水
溶液50μeと、ポテトデキストロース培地で培養した
イネごま葉枯病菌(0OChli−obolus m1
yabeanus )の1%グルコース含有胞子懸濁液
50μeを分注1−て混合したのち27℃の溝室で12
時間培養後、胞子の発芽数を顕微鏡で計測した。Test Example 4 Rice Sesame Leaf Blight Spore Germination Inhibition Test 50 μe of the aqueous solution of Compound A in Example 2 at a predetermined concentration was placed on a pole glass and a rice sesame leaf blight fungus (0OCchli-obolus m1) was cultured in a potato dextrose medium.
After dispensing 50 μe of a 1% glucose-containing spore suspension of P. yabeanus and mixing, it was heated in a groove chamber at 27°C for 12 hours.
After culturing for an hour, the number of germinated spores was counted using a microscope.
結果は、表−4に示す通りであった。The results were as shown in Table-4.
表−4 率を示す。Table-4 Show rate.
一15=-15=
Claims (1)
は1分子のグルクロン酸、1分子のグルコース及び2分
子のガラクトースからなり、かつグルクロン酸がアグリ
コンに直接結合してなる糖鎖を示す。〕 で表わされるトリテルペン系サポニン化合物。(1) The following formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, R_1 represents a hydrogen atom or an acetyl group, and R_2
indicates a sugar chain consisting of one molecule of glucuronic acid, one molecule of glucose, and two molecules of galactose, and in which glucuronic acid is directly bonded to an aglycone. ] A triterpene saponin compound represented by
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12640984A JPS617290A (en) | 1984-06-21 | 1984-06-21 | Triterpene-type saponin compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12640984A JPS617290A (en) | 1984-06-21 | 1984-06-21 | Triterpene-type saponin compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS617290A true JPS617290A (en) | 1986-01-13 |
Family
ID=14934440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12640984A Expired - Lifetime JPS617290A (en) | 1984-06-21 | 1984-06-21 | Triterpene-type saponin compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS617290A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01146820U (en) * | 1988-04-01 | 1989-10-11 | ||
| JPH0480315U (en) * | 1990-11-26 | 1992-07-13 | ||
| WO1997029630A1 (en) * | 1996-02-14 | 1997-08-21 | Zhejiang Agricultural University | A method of preventing animals from diseases and improving immune function of animals |
| US6251951B1 (en) | 1994-12-30 | 2001-06-26 | Proguard, Inc | Use of flavonoid and aromatic aldehydes as pesticides |
| WO2001060153A3 (en) * | 2000-02-15 | 2002-05-16 | Northern Quinoa Corp | Method and composition for protecting plants from disease |
| EP1867230A3 (en) * | 2006-05-29 | 2008-04-02 | Nor-Natur ApS | A natural product having a fungus inhibiting effect on specific fungal pathogens and a growth promoting effect for improving plant production |
| CN104151377A (en) * | 2014-08-07 | 2014-11-19 | 雷炳忠 | Technology and method for extraction of teasaponin from Camellia oleifera Abel seed meal |
-
1984
- 1984-06-21 JP JP12640984A patent/JPS617290A/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01146820U (en) * | 1988-04-01 | 1989-10-11 | ||
| JPH0480315U (en) * | 1990-11-26 | 1992-07-13 | ||
| US6251951B1 (en) | 1994-12-30 | 2001-06-26 | Proguard, Inc | Use of flavonoid and aromatic aldehydes as pesticides |
| WO1997029630A1 (en) * | 1996-02-14 | 1997-08-21 | Zhejiang Agricultural University | A method of preventing animals from diseases and improving immune function of animals |
| US6007822A (en) * | 1996-02-14 | 1999-12-28 | Zhejian Agricultural University | Animal feed compositions and uses of triterpenoid saponin obtained from Camellia L. plants |
| WO2001060153A3 (en) * | 2000-02-15 | 2002-05-16 | Northern Quinoa Corp | Method and composition for protecting plants from disease |
| EP1867230A3 (en) * | 2006-05-29 | 2008-04-02 | Nor-Natur ApS | A natural product having a fungus inhibiting effect on specific fungal pathogens and a growth promoting effect for improving plant production |
| CN104151377A (en) * | 2014-08-07 | 2014-11-19 | 雷炳忠 | Technology and method for extraction of teasaponin from Camellia oleifera Abel seed meal |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zehavi et al. | Light-sensitive glycosides. I. 6-Nitroveratryl. beta.-D-glucopyranoside and 2-nitrobenzyl. beta.-D-glucopyranoside | |
| Key et al. | Enhancement by auxin of ribonucleic acid synthesis in excised soybean hypocotyl tissue | |
| Lemmich et al. | Molluscicidal saponins from Catunaregam nilotica | |
| Davis et al. | Host-pathogen interactions. XXX. Characterization of elicitors of phytoalexin accumulation in soybean released from soybean cell walls by endopolygalacturonic acid lyase | |
| JPS617290A (en) | Triterpene-type saponin compound | |
| Brown et al. | Cardenolides of Asclepias syriacal., Probable Structure of Syrioside and Syriobioside. Glycosides and aglycones, 334th communication | |
| CN111704544B (en) | Labdane diterpenoid compound and separation method and application thereof | |
| CN101156865B (en) | See the anti-tumor application of cardiac glycosides in Xuefengthroat | |
| Xu et al. | 3-Pentanol glycosides from root nodules of the actinorhizal plant Alnus cremastogyne | |
| CN118496132A (en) | Thiobenzoate compound and preparation method and application thereof | |
| Grossmann et al. | Effects of NDA, a new plant growth retardant, on cell culture growth of Zea mays L. | |
| CN101805385A (en) | Neoflavonoid compounds separated and purified from Tridax procumbens and preparation method thereof | |
| CN107805188B (en) | Biphenyl compound and preparation method and application thereof | |
| CN102432666B (en) | Novel compound separated from Actinostemma tenerum as well as preparation method and application thereof | |
| Entlicher et al. | Glycosides IV. Isopyroside: the native monoacetylarbutin of pear leaves | |
| CN113929726B (en) | Mogrol derivative compound and preparation method and application thereof | |
| CN114164241B (en) | Polysaccharide, sulfated product thereof and application of sulfated product in preparation of anti-inflammatory drugs | |
| CN113024494B (en) | Phenanthrene compound, preparation method and application | |
| CN113416123B (en) | Monomer compound separated from trichoderma reesei strain, preparation method and application | |
| Mitchell et al. | Enhanced 3-methoxytyramine levels in crown gall tumours and other undifferentiated plant tissues | |
| Parveen et al. | A novel 6-hydroxy-8, 11, 11-trimethyl-bicyclo [7.2. 0] undec-4-ene-4-carboxylic acid: a potent antioxidant agent from Iphiona scabra | |
| JPH0381226A (en) | Extract of eucommia ulmoides seed origin | |
| Kazerovskis | Preliminary phytochemical study of Lychnis alba saponin | |
| CN108440269B (en) | A class of anthracyclines and their aglycone compounds, preparation methods and applications in the preparation of drugs for treating cancer | |
| CN118388334A (en) | Phenanthrene ketone compound, preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |